Related Experiment Videos
Do minocycline and other tetracyclines have a place in rheumatology?
E Toussirot1, J Despaux, D Wendling
1Rheumatology Department, J. Minjoz Teaching Hospital, Besançon, France.
Abstract:
Tetracyclines are a family of antimicrobials with activity against a broad range of organisms including those that develop intracellularly. Links have been reported between some infections and some inflammatory joint diseases, with the most notable example involving mycoplasmas and rheumatoid arthritis. Reactive arthritides are known to be triggered by organisms found in the gastrointestinal or genitourinary tract, and antigenic material from these organisms has recently been demonstrated in synovial tissue from patients with reactive arthritis. These facts led to the hypothesis that tetracyclines may be useful in rheumatoid arthritis and reactive arthritis. Two controlled studies found that minocycline benefited rheumatoid arthritis patients when it was given either as an adjunct to another second-line treatment or as the only slow-acting drug. Lymecycline has been found to expedite recovery from reactive arthritis due to Chlamydia trachomatis, and tetracycline to decrease the incidence of reactive arthritis due to sexually-transmitted diseases. The safety profiles of these treatments were acceptable in all available studies but require further investigation during long-term administration. The benefits may be related to the immunomodulating effects of tetracyclines and/or to their ability to inhibit metalloproteases such as collagenases. Whether tetracycline therapy influences the course of radiologic lesions in rheumatoid arthritis remains unknown. However, minocycline therapy has given sufficient proof of its efficacy to make it an attractive alternative in rheumatoid arthritis.
Insights
Tetracyclines, like minocycline, show promise in treating rheumatoid arthritis and reactive arthritis. These antimicrobials may offer benefits beyond their antibacterial effects, potentially through immunomodulation.
Area of Science:
- Rheumatology
- Pharmacology
- Immunology
Background:
- Infections are linked to inflammatory joint diseases like rheumatoid arthritis (RA) and reactive arthritis.
- Organisms from the GI or GU tract can trigger reactive arthritis, with evidence found in synovial tissue.
- Tetracyclines are broad-spectrum antimicrobials effective against intracellular pathogens.
Purpose of the Study:
- To investigate the potential therapeutic role of tetracyclines in rheumatoid arthritis and reactive arthritis.
- To evaluate the efficacy of specific tetracyclines, such as minocycline, lymecycline, and tetracycline, in managing these conditions.
Main Methods:
- Review of controlled studies and clinical observations on tetracycline use in arthritis.
- Analysis of treatment outcomes for minocycline in RA, and lymecycline/tetracycline in reactive arthritis.
Main Results:
- Minocycline demonstrated benefits as an adjunct or sole therapy for rheumatoid arthritis patients.
- Lymecycline expedited recovery from Chlamydia trachomatis-induced reactive arthritis.
- Tetracycline reduced the incidence of reactive arthritis linked to STDs.
Conclusions:
- Tetracyclines, particularly minocycline, represent a viable alternative treatment for rheumatoid arthritis.
- Further research is needed to understand long-term safety and effects on radiologic progression.
- Potential benefits may stem from immunomodulatory actions and metalloprotease inhibition.